Cyndeo Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
108,426
+3,929
+4% +$460K 0.66% 39
2026
Q1
$12.6M Sell
104,497
-18,586
-15% -$2.15M 0.66% 41
2025
Q4
$13M Buy
123,083
+2,598
+2% +$244K 0.7% 36
2025
Q3
$10.1M Buy
120,485
+96,254
+397% +$7.93M 0.56% 45
2025
Q2
$1.92M Sell
24,231
-302
-1% -$24K 0.11% 163
2025
Q1
$2.2M Sell
24,533
-697
-3% -$65.1K 0.14% 153
2024
Q4
$2.51M Sell
25,230
-122
-0.5% -$12.6K 0.17% 143
2024
Q3
$2.88M Buy
25,352
+1,005
+4% +$119K 0.2% 133
2024
Q2
$3.01M Buy
24,347
+4,947
+26% +$637K 0.24% 121
2024
Q1
$2.56M Buy
19,400
+73
+0.4% +$9K 0.21% 135
2023
Q4
$2.11M Sell
19,327
-162
-0.8% -$16.8K 0.2% 133
2023
Q3
$2.01M Sell
19,489
-1,496
-7% -$161K 0.21% 126
2023
Q2
$2.42M Buy
20,985
+1,759
+9% +$200K 0.25% 109
2023
Q1
$2.05M Buy
19,226
+9,336
+94% +$1.01M 0.22% 123
2022
Q4
$1.1M Buy
+9,890
New +$1.01M 0.13% 162

Other funds holding MRK

Cyndeo Wealth Partners's MRK Position: Q2 2026 in Review

Cyndeo Wealth Partners increased its Merck (MRK) stake by 3.8% in Q2 2026, buying an estimated $460K and bringing the position to 108,426 shares worth $13.9M. The position accounts for 0.66% of the portfolio, ranked #39.

Cyndeo Wealth Partners first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cyndeo Wealth Partners held 108,426 shares of Merck worth $13.9M as of Q2 2026.
  • Cyndeo Wealth Partners bought 3,929 Merck shares in Q2 2026, an estimated $460K.
  • Merck made up 0.66% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #39 holding.
  • Cyndeo Wealth Partners first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.